•
Sep 30, 2024

Immix Biopharma Q3 2024 Earnings Report

EPS
-$0.24
Previous year: -$0.23
+4.3%
Gross Profit
$0
Previous year: -$1.38K
-100.0%
Cash and Equivalents
$19.7M
Previous year: $19.6M
+0.6%
Free Cash Flow
-$4.31M
Previous year: -$3.13M
+37.8%
Total Assets
$25.1M
Previous year: $22.5M
+11.9%

Immix Biopharma

Immix Biopharma